SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-052396
Filing Date
2023-10-06
Accepted
2023-10-06 16:07:10
Documents
13
Period of Report
2023-10-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K amam-20231006.htm   iXBRL 8-K 61222
  Complete submission text file 0000950170-23-052396.txt   217972

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amam-20231006_pre.xml EX-101.PRE 14510
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amam-20231006.xsd EX-101.SCH 3707
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amam-20231006_lab.xml EX-101.LAB 18741
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amam-20231006_def.xml EX-101.DEF 14450
7 EXTRACTED XBRL INSTANCE DOCUMENT amam-20231006_htm.xml XML 6521
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 231314290
SIC: 2836 Biological Products, (No Diagnostic Substances)